These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8828949)

  • 1. Safety and side effects of i.v. immunoglobulin therapy.
    Nydegger UE
    Clin Exp Rheumatol; 1996; 14 Suppl 15():S53-7. PubMed ID: 8828949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature.
    Schiavotto C; Ruggeri M; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):35-40. PubMed ID: 8039756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Side-effects of intravenous immune globulins.
    Duhem C; Dicato MA; Ries F
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):79-83. PubMed ID: 8033440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aseptic meningitis: a frequent side-effect of intravenous immunoglobulin?
    Preminger-Shapiro R; Nussinovitch M; Soen G; Varsano I
    Eur J Pediatr; 1995 Oct; 154(10):866-7. PubMed ID: 8529693
    [No Abstract]   [Full Text] [Related]  

  • 5. Developing practice guidelines for the administration of intravenous immunoglobulin.
    Murphy E; Martin S; Patterson JV
    J Infus Nurs; 2005; 28(4):265-72. PubMed ID: 16106210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nurse's role in administration of intravenous immunoglobulin therapy.
    Kirmse J
    Home Healthc Nurse; 2009 Feb; 27(2):104-11; quiz 112-3. PubMed ID: 19212223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intravenous immunoglobulins and aseptic meningitis].
    Mselati JC; Carlier JC; Routon MC; Noui Mehidi F; de Gennes C
    Arch Fr Pediatr; 1992 Mar; 49(3):216. PubMed ID: 1610283
    [No Abstract]   [Full Text] [Related]  

  • 8. [Aseptic meningitis secondary to intravenous immunoglobulin treatment in Kawasaki disease].
    García Norniella B; Morán Poladura M; Fernández Díaz M; Fernández Fernández E; Suárez Castañón C
    An Pediatr (Barc); 2011 Jul; 75(1):79-80. PubMed ID: 21420919
    [No Abstract]   [Full Text] [Related]  

  • 9. Human intravenous immunoglobulin-induced aseptic meningitis: a case report.
    Chaabane A; Hamzaoui A; Aouam K; Klai R; Fredj NB; Boughattas NA; Mahjoub S
    J Clin Pharmacol; 2012 Feb; 52(2):279-81. PubMed ID: 21257801
    [No Abstract]   [Full Text] [Related]  

  • 10. [Aseptic meningitis during treatment with immunoglobulins].
    Sirvent N; Monpoux F; Benet L; Mariani R
    Arch Pediatr; 1996 Aug; 3(8):830-1. PubMed ID: 8998543
    [No Abstract]   [Full Text] [Related]  

  • 11. [The use of human immunoglobulins--adverse reactions].
    Pituch-Noworolska A; Błaut-Szlósarczyk A; Zwonarz K
    Pol Merkur Lekarski; 2010 Sep; 29(171):202-5. PubMed ID: 20931833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug induced aseptic meningitis caused by intravenous immunoglobulin therapy.
    Mullane D; Williams L; Merwick A; Tobin WO; McGuigan C
    Ir Med J; 2012 Jun; 105(6):182-3. PubMed ID: 22973657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recalcitrant pemphigus vulgaris: aseptic meningitis associated with intravenous immunoglobulin therapy and successful treatment with rituximab.
    Ventura F; Rocha J; Fernandes JC; Machado A; Brito C
    Int J Dermatol; 2013 Apr; 52(4):501-2. PubMed ID: 23451774
    [No Abstract]   [Full Text] [Related]  

  • 14. Aseptic meningitis and intravenous gammaglobulin treatment.
    Ozsoylu S
    Am J Dis Child; 1993 Feb; 147(2):129-30. PubMed ID: 8489588
    [No Abstract]   [Full Text] [Related]  

  • 15. [Aseptic meningitis as a complication of immunoglobulin treatment in myasthenia gravis].
    Puy-Nunez A; Dacosta-Balboa M; Cabo-Lopez I; Canneti B; Lopez-Ferreiro A; Rodriguez-Alvarez JR; Rodriguez-Regal A; Mourino-Sestelo MA
    Rev Neurol; 2016 May; 62(10):478-9. PubMed ID: 27149191
    [No Abstract]   [Full Text] [Related]  

  • 16. Substitution therapy in immunodeficient patients with anti-IgA antibodies or severe adverse reactions to previous immunoglobulin therapy.
    Eijkhout HW; van den Broek PJ; van der Meer JW
    Neth J Med; 2003 Jun; 61(6):213-7. PubMed ID: 12948165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin-induced aseptic meningitis in a patient with Miller Fisher syndrome.
    Maldonado Slootjes S; Guilmot A; Dubuisson N; van Pesch V; Elsankari S
    Acta Neurol Belg; 2020 Aug; 120(4):1015-1016. PubMed ID: 32449133
    [No Abstract]   [Full Text] [Related]  

  • 18. Aseptic meningitis and abducens nerve palsy as a serious side effect of high dose intravenous immunoglobulin used in a patient with renal transplantation.
    Wright SE; Shaikh ZH; Castillo-Lugo JA; Tanriover B
    Transpl Infect Dis; 2008 Jul; 10(4):294-7. PubMed ID: 18086279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse effects of IgG therapy.
    Berger M
    J Allergy Clin Immunol Pract; 2013; 1(6):558-66. PubMed ID: 24565701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aseptic meningitis following treatment with immunoglobulins: physiopathological and prognostic value of screening].
    Oddou S; Molinier S; Coso D; Boulet JM; Gastaut JA; Bouabdallah R
    Presse Med; 1995 May; 24(19):916. PubMed ID: 7638138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.